Clinical features and prognostic analysis of posterior reversible encephalopathy syndrome in children
- PMID: 35373858
- DOI: 10.1002/jdn.10184
Clinical features and prognostic analysis of posterior reversible encephalopathy syndrome in children
Abstract
Background: We aimed to investigate the clinical features and prognosis of posterior reversible encephalopathy syndrome (PRES) in children.
Methods: Clinical data of children with PRES diagnosed at the Children's Hospital of Chongqing Medical University from June 2015 to May 2019 were retrospectively analyzed.
Results: The study enrolled 47 patients with a mean age at diagnosis of 8.79 ± 3.72 years (range, 2-15 years). PRES causes included renal disorder (29/47), hematological disease (13/47), and hypertension (5/47). PRES manifested as seizure (43/47), headache (28/47), visual impairment (18/47), dizziness (18/47), vomiting (18/47), and mental and behavioral abnormalities (17/47). Forty-six children had hypertension (46/47) at PRES onset. Magnetic resonance imaging (MRI) mainly involved the parietal and occipital lobes (42/47), 38 cases were mild (38/47), seven were moderate (7/47), and two were severe (2/47). The clinical symptoms of 41 patients (41/47) were relieved within 1-2 weeks. Thirty-seven children were followed up for 7-54 months (modified Rankin Scale). Twenty-five children had favorable outcomes (25/37). Twelve children had adverse outcomes (12/37), including epilepsy, disorders of consciousness, visual impairment, and mental decline. Analysis of single factors revealed that severity on MRI, length of in-hospital stay, and mental and behavioral abnormalities were related to adverse outcomes after PRES. Analysis of multiple factors revealed that severity on MRI and length of in-hospital stay were independent risk factors for PRES.
Conclusion: Pediatric PRES is a clinical radiographic syndrome with multiple etiologies. Most patients have a good prognosis. Severity on MRI and length of in-hospital stay are independent risk factors.
Keywords: children; clinical feature; posterior reversible encephalopathy syndrome; prognosis.
© 2022 International Society for Developmental Neuroscience.
References
REFERENCES
-
- Alhilali, L. M., Reynolds, A. R., & Fakhran, S. (2014). A multi-disciplinary model of risk factors for fatal outcome in posterior reversible encephalopathy syndrome. Journal of the Neurological Sciences, 347, 59-65. https://doi.org/10.1016/j.jns.2014.09.019
-
- Aravind, T., Thavamani, A., Umapathi, K. K., Puliyel, M., Super, D., Allareddy, V., & Ghori, A. (2020). Epidemiology, comorbidities, and outcomes of posterior reversible encephalopathy syndrome in children in the United States. Pediatric Neurology, 103, 21-26. https://doi.org/10.1016/j.pediatrneurol.2019.07.007
-
- Archana, H., Hinduja, A., Habetz, K., Raina, S., Ramakrishnaiah, R., & Fitzgerald, R. T. (2017). Predictors of poor outcome in patients with posterior reversible encephalopathy syndrome. The International Journal of Neuroscience, 127(2), 135-144. https://doi.org/10.3109/00207454.2016.1152966
-
- Ay, H., Buonanno, F. S., Schaefer, P. W., Le, D. A., Wang, B., Gonzalez, R. G., & Koroshetz, W. J. (1998). Posterior leukoencephalopathy without severe hypertension: Utility of diffusion-weighted MRI. Neurology, 51(5), 1369-1376. [PubMed: 9818862]. https://doi.org/10.1212/WNL.51.5.1369
-
- Bartynski, W. S. (2008). Posterior reversible encephalopathy syndrome, part 2: Controversies surrounding pathophysiology of vasogenic edema. AJNR. American Journal of Neuroradiology, 29(6), 1043-1049. [PubMed: 18403560]. https://doi.org/10.3174/ajnr.A0929
MeSH terms
LinkOut - more resources
Full Text Sources
Medical